Economiic Home Method Watch Market RSI Search

Monopar Therapeutics Inc. MNPR

Sector:

Healthcare

Industry:

Biotechnology

Description:

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.
Monopar Therapeutics Inc. website

Recent Quarter:

2024-08-09

Upcoming Quarter:

2024-11-14

Annual Reports

Date2024-03-28
Revenue 0
Net Income -8,402,196
EPS -3.04
Basic Shares 2,764,000
Diluted Shares 2,764,790
Report Link
Date2023-03-23
Revenue 0
Net Income -10,494,399
EPS -0.83
Basic Shares 12,718,166
Diluted Shares 12,718,166
Report Link
Date2022-03-24
Revenue 0
Net Income -9,079,200
EPS -0.73
Basic Shares 12,472,217
Diluted Shares 12,472,217
Report Link
Date2021-03-25
Revenue 0
Net Income -6,222,671
EPS -0.57
Basic Shares 10,958,256
Diluted Shares 10,958,256
Report Link
Date2020-03-27
Revenue 0
Net Income -4,125,987
EPS -0.39
Basic Shares 10,587,632
Diluted Shares 10,587,632
Report Link
Date2019-02-26
Revenue 0
Net Income -3,227,932
EPS -0.31
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2018-03-26
Revenue 0
Net Income -16,554,872
EPS -1.59
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2016-12-31
Revenue 0
Net Income -1,185,597
EPS -0.11
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2015-12-31
Revenue 0
Net Income -687,311
EPS -0.0649
Basic Shares 10,587,632
Diluted Shares 10,587,632
Report Link

Annual Ratios

Date2023-12-31
PE -0.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -14.36
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -22.05
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -53.89
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -212.99
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -427.76
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -83.41
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-12-31
PE -1164.63
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-12-31
PE -2041.09
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-08-09
Revenue 0
Net Income -1,715,309
EPS -0.49
Basic Shares 3,502,927
Diluted Shares 3,502,927
Report Link
Date2024-05-09
Revenue 0
Net Income -1,641,226
EPS -0.1
Basic Shares 15,979,816
Diluted Shares 15,979,816
Report Link
Date2024-03-28
Revenue 0
Net Income -1,813,915
EPS -0.12
Basic Shares 14,904,497
Diluted Shares 14,904,497
Report Link
Date2023-11-09
Revenue 0
Net Income -1,953,734
EPS -0.14
Basic Shares 14,118,397
Diluted Shares 14,118,397
Report Link
Date2023-08-10
Revenue 0
Net Income -2,199,991
EPS -0.16
Basic Shares 13,420,029
Diluted Shares 13,420,029
Report Link
Date2023-05-11
Revenue 0
Net Income -2,344,068
EPS -0.18
Basic Shares 13,105,831
Diluted Shares 13,105,831
Report Link
Date2023-03-23
Revenue 0
Net Income -2,882,797
EPS -0.22
Basic Shares 12,946,573
Diluted Shares 12,946,573
Report Link
Date2022-11-10
Revenue 0
Net Income -2,399,647
EPS -0.19
Basic Shares 12,754,685
Diluted Shares 12,754,685
Report Link
Date2022-08-11
Revenue 0
Net Income -2,762,097
EPS -0.22
Basic Shares 12,632,381
Diluted Shares 12,632,381
Report Link
Date2022-05-12
Revenue 0
Net Income -2,455,794
EPS -0.19
Basic Shares 12,604,443
Diluted Shares 12,604,443
Report Link
Date2022-03-24
Revenue 0
Net Income -2,680,593
EPS -0.21
Basic Shares 12,582,728
Diluted Shares 12,582,728
Report Link
Date2021-11-12
Revenue 0
Net Income -2,458,443
EPS -0.2
Basic Shares 12,582,728
Diluted Shares 12,582,728
Report Link
Date2021-08-12
Revenue 0
Net Income -2,080,169
EPS -0.17
Basic Shares 12,569,933
Diluted Shares 12,569,933
Report Link
Date2021-05-13
Revenue 0
Net Income -1,884,019
EPS -0.16
Basic Shares 12,139,422
Diluted Shares 12,139,422
Report Link
Date2021-03-25
Revenue 0
Net Income -2,128,448
EPS -0.19
Basic Shares 11,116,409
Diluted Shares 11,116,409
Report Link
Date2020-11-12
Revenue 0
Net Income -1,639,438
EPS -0.15
Basic Shares 11,116,409
Diluted Shares 11,116,409
Report Link
Date2020-08-06
Revenue 0
Net Income -1,445,810
EPS -0.14
Basic Shares 10,648,285
Diluted Shares 10,648,285
Report Link
Date2020-05-07
Revenue 0
Net Income -1,090,877
EPS -0.1
Basic Shares 10,608,199
Diluted Shares 10,608,199
Report Link
Date2020-03-27
Revenue 0
Net Income -1,206,859
EPS -0.11
Basic Shares 10,587,632
Diluted Shares 10,608,199
Report Link
Date2019-11-12
Revenue 0
Net Income -736,080
EPS -0.0706
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2019-08-08
Revenue 0
Net Income -905,700
EPS -0.0869
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2019-05-10
Revenue 0
Net Income -1,376,235
EPS -0.13
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2019-02-26
Revenue 0
Net Income -890,461
EPS -0.0854
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2018-11-09
Revenue 0
Net Income -640,184
EPS -0.0614
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2018-08-09
Revenue 0
Net Income -820,939
EPS -0.0713
Basic Shares 11,513,644
Diluted Shares 11,513,644
Report Link
Date2018-12-11
Revenue 0
Net Income -876,347
EPS -0.0841
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2018-03-26
Revenue 0
Net Income -713,583
EPS -0.0685
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2017-09-30
Revenue 0
Net Income -14,876,934
EPS -1.43
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2017-06-30
Revenue 0
Net Income -591,438
EPS -0.0568
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2017-03-31
Revenue 0
Net Income -372,915
EPS -0.0358
Basic Shares 10,420,966
Diluted Shares 10,420,966
Report Link
Date2016-12-31
Revenue 0
Net Income -320,473
EPS -0.035
Basic Shares 9,288,983
Diluted Shares 9,289,207
Report Link
Date2016-09-30
Revenue 0
Net Income -193,112
EPS -0.022
Basic Shares 8,722,992
Diluted Shares 8,723,327
Report Link
Date2016-06-30
Revenue 0
Net Income -336,006
EPS -0.0412
Basic Shares 8,157,000
Diluted Shares 8,157,447
Report Link
Date2016-03-31
Revenue 0
Net Income -336,006
EPS -0.0412
Basic Shares 8,157,000
Diluted Shares 8,157,447
Report Link

Quarterly Ratios

Date2024-06-30
PE -1.89
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -8.28
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -3.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -5.60
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -6.53
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -9.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -13.30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -10.10
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -13.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -16.36
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -18.83
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -31.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -44.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -49.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -39.95
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -45.36
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -68.68
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -87.11
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -182.04
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE -468.96
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE -381.14
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE -250.83
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -387.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-09-30
PE -539.21
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE -464.58
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE -393.90
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -483.75
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-09-30
PE -23.20
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-06-30
PE -583.65
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-03-31
PE -925.67
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-12-31
PE -960.14
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-09-30
PE -1496.28
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-06-30
PE -804.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-03-31
PE -804.15
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

58.00

Price:

$32.66

Market Cap:

114,975,284

EPS TTM:

-0.85

PE Ratio:

-8.65

PEPSG:

0.3158

Fwd PE:

-2.73

Volume:

825,475

2 Year Price Change

3.186

Index 2 Year Price Change

1.498

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.922
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: